Czasopismo Journal of Contemporary Brachytherapy 2022

Editorial

Letter from the Editor-in-Chief

Adam Chicheł

View text

Original paper

An Asian multi-national, multi-institutional, retrospective study on image-guided brachytherapy in cervical adenocarcinoma and adenosquamous carcinoma

Noriyuki Okonogi, Naoya Murakami, Ken Ando, Masumi Murata, Kazutoshi Murata, Tomomi Aoshika, Shingo Kato, Anneyuko I Saito, Joo-Young Kim, Yasuo Yoshioka, Shuhei Sekii, Kayoko Tsujino, Chairat Lowanichkiattikul, Poompis Pattaranutaporn, Yuko Kaneyasu, Tomio Nakagawa, Miho Watanabe, Takashi Uno, Rei Umezawa, Keiichi Jingu, Ayae Kanemoto, Masaru Wakatsuki, Katsuyuki Shirai, Hiroshi Igaki, Tatsuya Ohno, Jun Itami

J Contemp Brachytherapy 2022; 14, 4: 311–320

DOI: https://doi.org/10.5114/jcb.2022.119451

Abstract View text

Original paper

Early clinical outcomes of hybrid brachytherapy for locally advanced cervical cancer: making adverse situations in a favorable scenario

Leonel Varela Cagetti, Christophe Zemmour, Eric Lambaudie, Magalie Provansal, Renaud Sabatier, Laura Sabiani, Guillaume Blache, Camille Jauffret, Marjorie Ferré, Agnès Tallet, Laurence Gonzague

J Contemp Brachytherapy 2022; 14, 4: 321–331

DOI: https://doi.org/10.5114/jcb.2022.118831

Abstract View text

Original paper

Prognostic factors for IB2-IIIB cervical cancer patients treated by radiation therapy with high-dose-rate brachytherapy in a single-institution study

Yu-Ting Xiu, Fan-Xu Meng, Zhuo Wang, Kang-Kang Zhao, Yun-Long Wang, Zhi-Shen Chen, Bao-Sheng Sun

J Contemp Brachytherapy 2022; 14, 4: 332–340

DOI: https://doi.org/10.5114/jcb.2022.118674

Abstract View text

Original paper

Quality of life and sexual functioning among endometrial cancer patients treated with one week adjuvant high-dose-rate vaginal brachytherapy schedule

Giuseppe Facondo, Gianluca Vullo, Vitaliana De Sanctis, Cecilia Vitiello, Luciano Nieddu, Marco Alfò, Claudia Scaringi, Francesca De Felice, Margherita Rotondi, Flavia De Giacomo, Ilary Ruscito, Maurizio Valeriani, Mattia Falchetto Osti

J Contemp Brachytherapy 2022; 14, 4: 341–346

DOI: https://doi.org/10.5114/jcb.2022.119198

Abstract View text

Original paper

Brachytherapy dose changes: comparing in-room and out-room image-guided brachytherapy. A randomized study

Pooriwat Muangwong, Ekkasit Tharavichitkul, Patumrat Sripan, Somvilai Chakrabandhu, Pitchayaponne Klunklin, Wimrak Onchan, Bongkot Jia-Mahasap, Razvan Galalae, Imjai Chitapanarux

J Contemp Brachytherapy 2022; 14, 4: 347–353

DOI: https://doi.org/10.5114/jcb.2022.118940

Abstract View text

Original paper

Control charts for evaluation of quality of low-dose-rate brachytherapy for prostate cancer

Nicola J. Nasser, Elantholi P. Saibishkumar, Yinkun Wang, Peter W.M. Chung, Stephen L. Breen

J Contemp Brachytherapy 2022; 14, 4: 354–363

DOI: https://doi.org/10.5114/jcb.2022.119513

Abstract View text

Original paper

Sarcopenia does not limit overall survival after interstitial brachytherapy for breast cancer liver metastases

Maximilian Thormann, Franziska Heitmann, Christine March, Maciej Pech, Peter Hass, Alexey Surov, Robert Damm, Jazan Omari

J Contemp Brachytherapy 2022; 14, 4: 364–369

DOI: https://doi.org/10.5114/jcb.2022.119515

Abstract View text

Original paper

Narrowing the difference in dose delivery for IOERT and IOBT for locally advanced and locally recurrent rectal cancer

An-Sofie E. Verrijssen, Wim J.F. Dries, Jeltsje S. Cnossen, Jacqueline Theuws, Heike M.U. Peulen, Hetty A. van den Berg, Dorien C. Rijkaart, Eva L.K. Voogt, Inger-Karine Kolkman-Deurloo, Joost Nuyttens, Harm J.T. Rutten, Jacobus W.A. Burger, Cathryn Huibregtse Bimmel-Nagel

J Contemp Brachytherapy 2022; 14, 4: 370–378

DOI: https://doi.org/10.5114/jcb.2022.118305

Abstract View text

Original paper

Commissioning of GPU-based multi-criteria optimizer combined with plan navigation tools for high-dose-rate brachytherapy

Cédric Bélanger, Sylviane Aubin, Luc Beaulieu, Éric Poulin

J Contemp Brachytherapy 2022; 14, 4: 379–389

DOI: https://doi.org/10.5114/jcb.2022.118995

Abstract View text

Original paper

Patient safety program and incident review of high-dose-rate brachytherapy at an academic center in Thailand

Lalida Tuntipumiamorn, Kanitta Kamplong, Bhuvadol Pengchantr, Kantarat Rojanapan, Porntip Iampongpaiboon, Yaowalak Chansilpa

J Contemp Brachytherapy 2022; 14, 4: 390–397

DOI: https://doi.org/10.5114/jcb.2022.118793

Abstract View text

Original paper

Dosimetric comparison of two afterloaders and treatment planning systems in vaginal high-dose-rate brachytherapy

Deborah C. Marshall, Julie R. Bloom, Zahra Ghiassi-Nejad, Vishal Gupta, Audrey Saitta, Allison Powers, Ren-Dih Sheu, Yeh-Chi Lo, Vishruta Dumane

J Contemp Brachytherapy 2022; 14, 4: 398–402

DOI: https://doi.org/10.5114/jcb.2022.118633

Abstract View text

Review paper

Iodine-125 seeds insertion with trans-arterial chemical infusion for advanced lung cancer: a meta-analysis

Jiao Hong, Yi-Bing Shi, Yu-Fei Fu, Lu-Lu Yang

J Contemp Brachytherapy 2022; 14, 4: 403–410

DOI: https://doi.org/10.5114/jcb.2022.118117

Abstract View text

Review paper

Prediction models for brachytherapy-induced rectal toxicity in patients with locally advanced pelvic cancers: a systematic review

Fariba Tohidinezhad, Yves Willems, Maaike Berbee, Evert Van Limbergen, Frank Verhaegen, Andre Dekker, Alberto Traverso

J Contemp Brachytherapy 2022; 14, 4: 411–422

DOI: https://doi.org/10.5114/jcb.2022.119427

Abstract View text

Letter from the Editor-in-Chief

An Asian multi-national, multi-institutional, retrospective study on image-guided brachytherapy in cervical adenocarcinoma and adenosquamous carcinoma

Early clinical outcomes of hybrid brachytherapy for locally advanced cervical cancer: making adverse situations in a favorable scenario

Prognostic factors for IB2-IIIB cervical cancer patients treated by radiation therapy with high-dose-rate brachytherapy in a single-institution study

Quality of life and sexual functioning among endometrial cancer patients treated with one week adjuvant high-dose-rate vaginal brachytherapy schedule

Brachytherapy dose changes: comparing in-room and out-room image-guided brachytherapy. A randomized study

Control charts for evaluation of quality of low-dose-rate brachytherapy for prostate cancer

Sarcopenia does not limit overall survival after interstitial brachytherapy for breast cancer liver metastases

Narrowing the difference in dose delivery for IOERT and IOBT for locally advanced and locally recurrent rectal cancer

Commissioning of GPU-based multi-criteria optimizer combined with plan navigation tools for high-dose-rate brachytherapy

Patient safety program and incident review of high-dose-rate brachytherapy at an academic center in Thailand

Dosimetric comparison of two afterloaders and treatment planning systems in vaginal high-dose-rate brachytherapy

Iodine-125 seeds insertion with trans-arterial chemical infusion for advanced lung cancer: a meta-analysis

Prediction models for brachytherapy-induced rectal toxicity in patients with locally advanced pelvic cancers: a systematic review

Coverage in

Indexed in

Integrated with

Editorial Policies